Myxredlin 00338-0126
Generic: Insulin Human
Product NDC
00338-0126- Manufacturer
- Baxter Healthcare Corporation
- Dosage Form
- Injection, Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- July 12, 2019
- Listing Expires
- December 31, 2026
- Application
- BLA208157
Need to source Myxredlin? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Insulin Human | 1 [iU]/mL |
Drug Class
Insulin [EPC]Insulin [CS]Insulin [EPC]
Packaging Options(1)
12 CONTAINER in 1 CARTON (0338-0126-12) / 100 mL in 1 CONTAINER